Full Text View
Tabular View
No Study Results Posted
Related Studies
Severe Anemia Treatment Trials, Pakistan
This study has been completed.
Study NCT00116493   Information provided by Johns Hopkins Bloomberg School of Public Health

First Received on June 29, 2005.   Last Updated on April 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
More general conditions related to this trial
Hematologic Diseases
Interventions listed in this trial
Iron-folic acid and mebendazole
Mebendazole
Multivitamins
Mebendazole + Multivitamin
Additional drug interventions recognized in this trial
Anthelmintics
Folic Acid
Iron
Piperazine
Piperazine citrate
Vitamin B Complex
More general drug interventions related to this trial
Anti-Infective Agents
Antimitotic Agents
Antinematodal Agents
Antineoplastic Agents
Antiparasitic Agents
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Tubulin Modulators
Vitamins
Sponsors listed in this trial
Johns Hopkins Bloomberg School of Public Health
Aga Khan University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services